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The green fluorescent protein (GFP)
of Aequorea victoria is frequently fused
to other proteins to serve as a reporter
for gene expression or the localization
of proteins in vivo. We report that
when a GFP fusion protein is
translated in vitro under standard
conditions, the GFP portion folds
efficiently and becomes fluorescent.
This provides a convenient method
for monitoring in vitro translation
efficiency of a fusion protein, and to
screen for improved mutants of GFP.
In addition, quantitation of the
translation product combined with
fluorescence microscopy of the
product immunoprecipitated onto
beads allows the determination of the
density of the fusion protein in
microscopic images.
A fusion of the tobacco mosaic
virus 30 kDa movement protein [1]
to the amino terminus of the S65T
mutant of GFP [2] was translated
using a standard rabbit reticulocyte
lysate system incorporating
35S-labeled methionine of known
specific radioactivity. The products
were electrophoresed using SDS
and polyacrylamide gel
electrophoresis (SDS–PAGE)
followed by autoradiography (Fig.
1a, lane 1). The major product
exhibited the expected mobility;
minor products of greater mobility
are presumed to arise from internal
initiation or premature termination.
Scintillation counting, combined
with knowledge of the number of
methionine residues per molecule of
the fusion protein, showed that each
microliter of the translation reaction
contained 3.8 × 10–15 moles of fusion
protein.
The GFP part of the fusion
protein folded properly, as shown by
its fluorescence emission spectrum
(Fig. 1b). A clear signal was readily
detected in as little as 2 ml of the
translation reaction diluted 100-fold,
corresponding to a fusion protein
concentration of approximately
4 × 10–11 M.
The fusion protein was immuno-
precipitated onto protein G–sepharose
beads using an anti-GFP antibody.
Only the major translation product
and a minor product, presumed to
arise from internal initiation 20 amino-
acids downstream from the amino
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Figure 1
(a) Autoradiogram of translation products
separated by SDS–PAGE. The cDNA
encoding the fusion protein was excised from
the pTMVM:Gfus plasmid [1] and inserted into
pSP64T [6]. SP6 transcript (3 mg) was added
to 60 ml rabbit reticulocyte lysate (Promega)
containing [35S[methionine. The control
sample had no transcript added. Reactions
were allowed to proceed for 2 h at 25°C, and
were then kept at 16°C for 4 h. To remove
unincorporated [35S]methionine, the samples
were diluted with phosphate-buffered saline
(PBS) and filtered four times in Millipore
ultrafree-MC low binding regenerated
cellulose filter units with a nominal molecular
weight limit of 30 kDa, which had been
prewashed with 1% bovine serum albumin
(BSA), 1% sucrose. Lane 1, translation
product; lane 2, control sample (no RNA); lane
3, immunoprecipitated translation product;
lane 4, immunoprecipitated control sample (no
RNA). Each lane contains the equivalent of a
0.25 ml sample of the original reaction.
Markers (in kDa) on the left. (b) Fluorescence
emission spectra of fusion protein translated in
vitro, diluted to various extents in PBS, and of
a control (no RNA) sample. The excitation
wavelength was 475 nm. A Hitachi F-2000
fluorescence spectrophotometer was used,
with a 10 nm bandpass for both the excitation
and emission monochrometers. Fluorescence
was stable for at least 3 days at 4°C.
(c) White light and fluorescence micrographs
of protein G–sepharose beads used to
immunoprecipitate varying amounts of fusion
protein translated in vitro. Each
immunoprecipitation reaction contained 1ml
protein G–sepharose 4 fast-flow bead slurry
(Pharmacia), containing about 630 beads, and
0.5 ml anti-GFP antibody (Clontech), in 500 ml
PBS containing 0.2% Triton X-100 (Sigma).
The reactions were shaken at 4°C for 16 h,
and the beads were washed once with PBS
containing 0.2% Triton X-100. Scintillation
counting showed that the efficiency of the
immunoprecipitation was about 60%
regardless of the amount of translation
reaction added to the beads. The beads were
examined with a Nikon Optiphot2-UD
microscope equipped with a B-2A FITC filter
set (450–490 excitation filter, 505 dichroic
mirror, 520 barrier filter) using an objective
with a numerical aperture of 0.50, and were
photographed on Kodak Ektachrome P1600
film. Beads used to immunoprecipitate a
control reaction (no RNA) showed no
fluorescence (not shown).
(a) (b) (c)
217
111
71
44
28
18
15
1 2 3 4 6
5
4
3
2
1
0
Fl
uo
re
sc
en
ce
 (a
rb
itr
ar
y 
un
its
)
490 500 510 520 530 540 550
Emission wavelength (nm)
White light 800 molecules per µm2
160 molecules per µm2 80 molecules per µm2
Dilution 1:10
1:40
1:80
1:160
Control
terminus, were recognized by the
antibody (Fig. 1a, lane 3).
Fluorescence from the beads was
easily detectable by fluorescence
photomicroscopy when the amount of
translation reaction added to an
immunoprecipitation corresponded to
as little as 1 nl per bead (Fig. 1c). This
is equivalent to about 2 × 106 protein
molecules per bead, giving a surface
density of about 80 molecules per
mm2. Even a density as low as about 8
molecules per mm2 could be seen in
the microscope (data not shown). The
true density of fluorescent molecules
may be even lower than indicated, as
the fraction of synthesized molecules
that adopted a fluorescent
conformation is not known. Each bead
is somewhat larger than a eukaryotic
cell (90 mm in diameter), suggesting
that a similarly small number of GFP-
fusion molecules could be detected in
a living cell, particularly if the protein
were localized; autofluorescence from
a cell, however, might place a lower
limit on this number [3].
Cell-free expression of GFP seems
ideal for the rapid development of
new GFP mutants with brighter
fluorescence or shifted spectra, based
on the recently determined crystal
structure [4,5]. Large numbers of
mutants could be screened rapidly by
using cell-free coupled
transcription–translation of cDNA
clones in microtiter plates. In addition,
the fusion of GFP to other proteins
provides a simple nonradioactive
method of measuring translation
efficiency, which could expedite the
optimization of translation of any
protein of interest. Furthermore, if
radiolabeled amino acids are
incorporated, fluorescence intensity
can be correlated with protein
quantity, allowing the determination
of the density of GFP-fusion protein
molecules in a microscopic image of a
living cell, a task which cannot easily
be accomplished by analysis in vivo.
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Medline
What is it famous for? In North
America, at least, it is the usual source
of bibliographic information for
biomedical scientists. They expect
the titles and abstracts of papers in
any worthy journal to be included in
Medline in a timely fashion.
What should it be infamous for? The
fact that there are still large gaps in
its coverage of the 1996 literature,
but that few people realize this. The
problem arose because of a labour
dispute a year ago, which stopped
data entry for so long that the
backlog has still not been cleared. In
many cases (this journal included),
issues from the middle of 1996 are
missing, whereas issues from the
beginning and end of the year are
included; exactly what you find at
any time depends on who is
providing you with Medline.
What does it cover? Medline and its
printed counterpart, Index Medicus,
contain the citation information and
author abstracts from about 3800 of
the estimated 14 000 biomedical
journals that are published worldwide.
This information is supplemented by
‘MeSH’ terms, a system of key words
that are helpful for searching, and
other indexing information.
How are the journals chosen? By the
US National Library of Medicine,
which runs Medline, with the advice
of a committee that meets three
times a year and considers new or
resubmitted titles, giving them
scores of between 0 and 5. Those
that score more than 4 (about 20%)
are accepted. Journals scoring 2–4
cannot be reconsidered for two
years, and a score below 2
necessitates a four-year wait before
resubmission.
How is the information gathered?
With few exceptions, the citation
information and the abstracts from
the journals are re-keyed by Medline
staff. They also have to select and
enter the MeSH terms. The
combination of these two processes
has always resulted in a considerable
lag before an issue of a journal is
covered by Medline, although some
journals are put on a ‘fast track’.
What is happening about the lag?
Labour problems apart, re-keying has
always incurred delay. To get around
this, the National Center for
Biotechnology Information at the
National Library of Medicine has
been given the task of developing
ways of handling electronic files
supplied by publishers. Its PubMed
project (http://www4.ncbi.nlm.nih.gov/
PubMed) now contains the entire
Medline database, together with
‘PreMedline’ records, which consist of
citation information and abstracts
before MeSH and other indexing
terms have been added. When
publishers have supplied this
information in the correct electronic
format, it can appear in PubMed with
next to no delay. Moreover, PubMed
provides links from each paper to the
full text online, where it is available.
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